Changing Roles
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Pharma's Almanac
PAO-08-24-RT-01Aug 07, 2024
Global Access
How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?
Pharma's Almanac
PAO-08-24-RT-02Aug 07, 2024
Commitment to ESG Principles
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
Pharma's Almanac
PAO-03-24-CL-03Mar 08, 2024
Accelerating Product Development
What strategies are being employed to accelerate product development and commercialization without compromising quality?
Pharma's Almanac
PAO-03-24-CL-02Mar 08, 2024
Roundtable
What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?
Pharma's Almanac
PAO-12-23-RT-02Dec 15, 2023
Roundtable
What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?
Pharma's Almanac
PAO-12-23-RT-01Dec 14, 2023
International Markets
In what international markets do you anticipate significant developments in the near future?
Pharma's Almanac
PAO-01-23-RT-02Jan 31, 2023
Disruptive Technology
What do you view as the most disruptive or transformational technology or development on the horizon?
Pharma's Almanac
PAO-01-23-RT-01Jan 31, 2023
Custom Lipid Nanoparticle Development
The Value of a Custom Lipid Solutions Provider for mRNA Delivery
Lauren Longobardi, Ph.D.; Rima Jaber, Ph.D.; Sebastian Detlefsen, Dr.-Ing.
Evonik
PAO-11-022-CL-17Jan 05, 2023
Future of the Industry
What key indicators do you look at to predict the future of this industry?
Pharma's Almanac
PAO-10-022--RT-02Oct 11, 2022
Sustainability
What is your plan to build a more sustainable business practice in the coming years?
Pharma's Almanac
PAO-10-022--RT-01Oct 11, 2022
mRNA Delivery
New Polymer-Lipid Delivery System for mRNA
Andrea Engel, Ph.D.; Philipp Heller, Ph.D.
Evonik
PAO-05-022-CL-09May 31, 2022
Leadership
Q: What’s the key to being a leader in the industry?
Pharma's Almanac
PAO-03-022-RT-02Mar 11, 2022
Milestones
Q: What important company milestone do you anticipate reaching in 2022?
Pharma's Almanac
PAO-03-022-RT-01Mar 11, 2022
Parenteral Drug Delivery
Innovating at the Forefront of mRNA LNP Therapies
Evonik
PAO-02-22-R250-08Feb 10, 2022
Personalized and Precision Medicine
Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?
Pharma's Almanac
PAO-12-21-RT-01Jan 07, 2022
Therapeutic Progress
Q: For what therapeutic area do you think we will see the greatest progress in the coming years?
Pharma's Almanac
PAO-12-21-RT-02Jan 07, 2022
Lipid Nanoparticles
Leveraging True Expertise and Flexibility for Lipid Nanoparticle Clinical Manufacturing
Cole Byvelds, P.Eng.; Kristina Parrant
Evonik
PA656Dec 14, 2021
Parenteral Manufacturing
Focus on Commercial Parenteral Manufacturing at Evonik
Caroline Hand; Maaike Everts, Ph.D.
Evonik
PAO-09-21-CL-15Oct 08, 2021
Lipid Nanoparticles
Advancing Novel Therapeutics with End-to-End Lipid Nanoparticle Development and Manufacturing
Natalia Zisman
Evonik
PAO-07-21-CL-02Jul 12, 2021